Advanced search×

Multiscale Measurements Distinguish Cellular and Interstitial Hindrances to Diffusion In Vivo

Biophys J 97(1):7 (2009) PMID 19580771

Molecular cancer therapy relies on interstitial diffusion for drug distribution in solid tumors. A mechanistic understanding of how tumor components affect diffusion is necessary to advance cancer drug development. Yet, because of limitations in current techniques, it is unclear how individual tissue components hinder diffusion. We developed multiscale fluorescence recovery after photobleaching (MS-FRAP) to address this deficiency. Diffusion measurements facilitated by MS-FRAP distinguish the diffusive hindrance of the interstitial versus cellular constituents in living tissue. Using multiscale diffusion measurements in vivo, we resolved the contributions of these two major tissue components toward impeding diffusive transport in solid tumors and subcutaneous tissue in mice. We further used MS-FRAP in interstitial matrix-mimetic gels and in vivo to show the influence of physical interactions between collagen and hyaluronan on diffusive hindrance through the interstitium. Through these studies, we show that interstitial hyaluronan paradoxically improves diffusion and that reducing cellularity enhances diffusive macromolecular transport in solid tumors.

Copyright © 2009 Elsevier Ltd. All rights reserved.

DOI: 10.1016/j.bpj.2009.03.064
Version: za2963e q8za0 q8zbd q8zcb q8zda q8zef q8zfe q8zgd

Similar articles you may find interesting…

  1. Fetuin-A ({alpha}2HS-glycoprotein) is a major serum adhesive protein that mediates growth signaling in breast tumor cells.

    J Biol Chem 285(53):41827-35 (2010) PMID 20956534

    We show that fetuin-A whose function in cellular attachment in tissue culture has been debated for many years, is indeed a major serum cell attachment factor particularly for tumor cells. We are able to report this because of a new purification strategy that has for the first time, given us a homoge...
  2. Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors.

    Proc Natl Acad Sci U S A 108(7):2909-14 (2011) PMID 21282607 PMCID PMC3041115

    We tested whether losartan--a clinically approved angiotensin II receptor antagonist with noted antifibrotic activity--can enhance the penetration and efficacy of nanomedicine. We found that losartan inhibited collagen I production by carcinoma-associated fibroblasts isolated from breast cancer biop...
  3. Notch leads lymphatics and links them to blood vessels.

    Arterioscler Thromb Vasc Biol 30(9):1682-3 (2010) PMID 20720193 PMCID PMC2945915